Tech Company Financing Transactions
CB Therapeutics Funding Round
re.Mind Capital joined a Series A funding round for CB Therapeutics. The round was announced on 5/11/2021.
Transaction Overview
Company Name
Announced On
5/11/2021
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
re.Mind Capital (Jan Hardorp)
Proceeds Purpose
This fresh round of funding for CB Therapeutics will allow us to rapidly accelerate our scaled up manufacturing and sale of cannabinoids and tryptamines.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2717 Loker Ave. West A
Carlsbad, CA 92010
USA
Carlsbad, CA 92010
USA
Phone
Website
Email Address
Overview
We Are Advancing Fermentation-based Cellular Agriculture and Neuroscience to Achieve Breakthroughs in Mental Healthcare. CB Therapeutics is producing natural molecules and their analogs as therapeutic compounds for clinical research and the commercial market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sher Butt
Chief Scientific Officer
Jacob Vogan
VP - Operations
Thanos Karavokiris
VP - R & D
Laura Peiffer
Browse more venture capital transactions:
Prev: 5/11/2021: FinLync venture capital transaction
Next: 5/12/2021: Nuvalent venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs